Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
>
21.02.2025 09:55:00

Philips and Mass General Brigham announce collaboration to improve patient care with live AI-powered insights

February 21, 2025

Integrating advanced data analytics into clinical practice to improve patient care

Amsterdam, The Netherlands and Cambridge, MA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Mass General Brigham (MGB), home to one of the largest hospital system-based research enterprises in the US, today announced a new collaboration to develop and deploy advanced data infrastructure and AI designed to integrate and process live healthcare data from a wide range of sources to improve patient care.

Today, healthcare providers often rely on disparate data sources, including static Electronic Medical Record (EMR) data, clinical notes, and isolated device alarms. By streaming accurate, reliable and detailed data from medical devices and other sources, Philips and MGB aim to create a scalable, unified, near real-time data and insights ecosystem. Powered by Philips software platforms, the collaboration aims to enable clinicians to capture, analyze, and react to data as it is available, potentially improving the effectiveness and efficiency of patient care.

"This exciting collaboration marks a key step forward in healthcare innovation, harnessing the full potential of AI and medical device data to advance patient safety, operational efficiency, clinician ergonomics, while opening new discovery possibilities,” said Dr. Tom McCoy, Medical Director of Biomedical Engineering at Massachusetts General Hospital. "By mobilizing previously siloed medical device data into an integrated high speed, high resiliency, real time data fabric we will be able to deliver the transformative potential of software to the patients who need it most."

The collaboration will leverage a combination of Philips technologies to unify active data streaming from medical devices at the bedside, such as ventilators and monitors, with other longitudinal clinical data, such as lab results and EMR data, to create a comprehensive and actionable data environment. Philips Capsule Medical Device Information Platform brings together data from different devices, allowing Philips Clinical Insights Manager to facilitate retrospective analysis and testing, and Philips Capsule Surveillance to leverage continuous algorithmic processing to deliver smart alerts into live clinical practice.

For the collaboration, Mass General Brigham is bringing together the expertise of its biomedical engineering team, clinical sub-specialists, digital teams and internal AI business unit (Mass General Brigham AI) with Philips’ research and business teams. The joint effort will deliver data insights, enhance data integration and foster the development of new algorithms, capable of identifying patient-cohort patterns and generating smart alerts for clinical intervention. These alerts will provide clinicians with actionable insights at critical moments to support better patient care.

An initial research program as part of the collaboration focuses on patients undergoing continuous, real-time heart monitoring. By analyzing this data, the research aims to improve early detection of cardiac events and other critical health issues, potentially saving lives and expediting treatment.

"This collaboration between Philips and Mass General Brigham represents a significant step forward in the integration of advanced data analytics into clinical practice,” said Betsabeh Madani Hermann, Global Head of Research at Philips. "By developing predictive data analytics and AI algorithms, key tools for enhancing patient care, we’re empowering clinicians and supporting better care for more people.”

For further information, please contact:

Anna Hogrebe
Philips Global External Relations
Tel.: +1 416 270 6757
E-Mail: anna.hogrebe@philips.com

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,800 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachments


Analysen zu Philips N.V.

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
27.02.25 Philips Outperform Bernstein Research
21.02.25 Philips Buy UBS AG
21.02.25 Philips Buy Goldman Sachs Group Inc.
20.02.25 Philips Halten DZ BANK
20.02.25 Philips Hold Deutsche Bank AG
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

3 Knaller-Aktien im BX Musterportfolio📈: LPL Finance, Blackstone & Ares Management mit François Bloch

Im BX Morningcall werden folgende Aktien analysiert und erklärt:
✅ SAP
✅ Dollarama
✅ Waste Connections

Pünktlich zum Börsenstart diskutieren Investment-Stratege François Bloch und Börsen-Experte David Kunz oder Olivia Hähnel über ausgewählte Top-Aktienwerte aus dem BX Musterportfolio.

👉🏽 https://bxplus.ch/bx-musterportfolio/

3 Knaller-Aktien im BX Musterportfolio📈: SAP, Dollarama & Waste Connections mit François Bloch

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 13’705.29 19.81 UBSIIU
Short 14’049.47 13.04 B6CSKU
Short 14’600.83 8.39 U5VSUU
SMI-Kurs: 13’166.68 03.03.2025 17:31:46
Long 12’620.47 19.37 B79S7U
Long 12’327.76 13.58 BIGS9U
Long 11’796.95 8.78 BWMS2U
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

Börse aktuell - Live Ticker

SMI nach neuem Allzeithoch schliesslich stark -- DAX endet nach Rekord erstmals über 23.000-Punkte-Marke -- Wall Street schliesst deutlich im Minus -- Asiatische Indizes letztlich uneinig

Der heimische Aktienmarkt zeigte sich in Rekordform grün, während der deutsche Aktienmarkt zum Wochenauftakt mit neuer Bestmarke höher notierte. Die Wall Street präsentierte sich zum Wochenanfang mit roten Vorzeichen. Am Montag fanden die wichtigsten asiatischen Märkten keine gemeinsame Richtung.

finanzen.net News

Datum Titel
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
{{ARTIKEL.NEWS.BODY.TITEL}}

Nachrichten

  • Nachrichten zu Aktien
  • Alle Nachrichten